Study of CM512 Injection in Subjects With Chronic Spontaneous Urticaria(CSU)

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 15, 2025

Primary Completion Date

November 2, 2026

Study Completion Date

January 14, 2027

Conditions

Chronic Spontaneous Urticaria (CSU)

Interventions

BIOLOGICAL

CM512 injection

subcutaneous injection

DRUG

placebo

subcutaneous injection

Trial Locations (1)

Tianjin Academy of Traditional Chinese Medicine Affiliate Hospital, Tianjin